Also known as Vistide™. This is a newer anti-viral drug originally developed for a different indication and now appearing to have value in the treatment of laryngeal papillomatosis. It is increasingly used as an adjunctive, off-label treatment for [intlink id=”222″ type=”post”]human papilloma virus[/intlink] infection in the larynx (aka recurrent respiratory papillomatosis (RRP) aka laryngeal papillomatosis).

Posted in Glossary.

Leave a Reply

Your email address will not be published. Required fields are marked *